IGURATIMOD 25mg. IP

A disease-modifying anti-rheumatic drug used mainly in autoimmune and inflammatory conditions. (Sisi Xie, 2020) Possesses anti-inflammatory, antifibrotic, anti-resorptive, immunomodulatory, and bone metabolism-regulating effects. Reduces the immune attack on joints and lowers substances that cause swelling and pain. (Sisi Xie, 2020) Lowers inflammatory markers, decreases abnormal immune responses, and helps rebalance immune cell function. (Shenyi Liu, 2025) Regulates bone health by promoting bone building and stopping the cells that cause bone loss. (Sisi Xie, 2020) A highly efficacious and safe DMARD for rheumatoid arthritis treatment, known for its potent anti-inflammatory effects. (Ke Gan, 2016) A valuable alternative in situations where conventional RA treatment or other DMARDs are ineffective. (Jie Li, 2019) A promising and safe treatment option for managing ankylosing spondylitis, osteoarthritis and rheumatoid arthritis. A potentially effective approach for improving symptoms and disease activity in patients with primary Sjögren’s syndrome. (Huihui Jiang, 2020)